52 results

• Epogen, Aranesp Misuse Rampant: Study

  August 10, 2011

  Staff Writers

  According to the findings of a new study, Anemia drugs like Epogen and Aranesp, are being widely misused.

• Aranesp, Procrit and Epogen Health Risks Call For Lower Doses: FDA

  June 27, 2011

  Staff Writers

  The increased risk of heart problems, strokes and death from Aranesp, Procrit and Epogen has led federal health regulators to...

• Epogen, Procrit May Increase Heart Attack Damage: Study

  May 17, 2011

  Staff Writers

  The findings of recent research suggest that using the anemia drugs Epogen and Procrit following a heart attack is not...

• Use of Anemia Drugs for Kidney Failure Supported by FDA Panel

  October 19, 2010

  Staff Writers

  Despite a potential risk of stroke associated with the use of Aranesp, Procrit and Epogen, an FDA advisory panel has...

• Procrit and Epogen Recall Issued Over Glass Flakes in Vials

  September 27, 2010

  Staff Writers

  A recall of Epogen and Procrit vials has been issued due to a risk that certain lots of the anemia...

• Anemia Drugs Increase Risk of Heart Problems, Death in Some Cases: Study

  September 20, 2010

  Staff Writers

  The findings of a new study indicate that people with chronic kidney disease and diabetes who respond poorly to certain...

• Supreme Court Rejects Appeal of Procrit Whistleblower Lawsuit

  June 24, 2010

  Staff Writers

  The U.S. Supreme Court has rejected an attempt by Johnson & Johnson to appeal a whistleblower lawsuit that claims the...

• Side Effects of Aranesp, Procrit and Epogen Lead to New FDA Restrictions

  February 17, 2010

  Staff Writers

  Concerns over the increased risk of heart attacks, blood clots, tumors and death from side effects of Aranesp, Procrit and...

• Aranesp, Epogen and Procrit Health Risks to be Reviewed Further by FDA

  January 8, 2010

  AboutLawsuits

  The FDA indicates that it will further examine the side effects of anemia drugs, including Aranesp, Epogen and Procrit, due...

• Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study

  November 11, 2009

  AboutLawsuits

  According to new research, the anti-anemia drugs Aranesp, Epogen and Procrit not only increase the risk of blood clots, but...